+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Heparin"

From
Global Heparin Market Outlook 2030 - Product Thumbnail Image

Global Heparin Market Outlook 2030

  • Report
  • October 2021
  • 154 Pages
  • Global
From
From
Research Report on China's Heparin Export 2023-2032 - Product Thumbnail Image

Research Report on China's Heparin Export 2023-2032

  • Report
  • January 2023
  • 50 Pages
  • China
From
P selectin inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

P selectin inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Heparin Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Heparin Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
From
From
Thrombocytopenia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Thrombocytopenia - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 112 Pages
  • Global
From
From
Loading Indicator

Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery. Heparin is available in both injectable and oral forms, and is typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage. Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases. Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more